Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: PRRT (177Lu-Dotatate) is a therapeutic option for advanced NETs (neuroendocrine tumours). Systemic inflammatory parameters, such as NLR, PLR, SII, and other ratios derived from complete blood counts, are considered prognostic markers in NETs and other malignancies.
Conference:
Presenting Author: Maciejewski A
Authors: Maciejewski A, Komarnicki P, Musiałkiewicz J, Gut P, Ruchała M,
Keywords: neuroendocrine tumour, PRRT, systemic inflammatory parameter, PLR, prognostic biomarker,
Introduction: The pathogenesis of mesenteric fibrosis in small intestinal neuroendocrine tumours (SI-NETs) is poorly understood, limiting development of effective treatments and biomarkers. A major barrier to research is the lack of disease models.
Conference:
Presenting Author:
Authors: Hodgetts H, Martins M, Luong T, Hall A, Webster A,
Keywords: small intestine, neuroendocrine, 3D model, hydrogel, fibrosis,
Introduction: Surgery is the only definitive therapy for neuroendocrine tumours (NET). In number of small intestine NET first symptom is ileus or perforation, lifesaving surgical procedures applied. Such cases have significant risk of recurrence.
Conference:
Presenting Author: Hajac �
Authors: Hajac L, Szewczyk K, Piwkowski P, Chowaniec Z, Mazurak J,
Keywords: radio guided surgery, Neuroendocrine tumour, early relapse,
Introduction: The clinical specificities of FM-NET have been poorly described.
Conference:
Presenting Author: Hunaut T
Authors: Hunaut T, Hercent A, Walter T, Buecher B, Lepage C,
Keywords: Small intestine neuroendocrine tumour, Familial carcinoid tumour,
Introduction: The study of small intestine neuroendocrine neoplasms (siNENs) is challenging due to their rarity and complexity. While transcriptomic subtypes have been identified, the mechanisms behind their progression are still unclear. The process of RNA splicing is often altered in cancer, and our group has described that such dysregulation is also present in various NENs.
Conference:
Presenting Author: Ibáñez Costa A
Authors: Ibáñez-Costa A, García Vioque V, Pedraza-Arévalo S, Hernando Cubero J, García A,
Keywords: small intestine neuroendocrine tumour, splicing, biomarker, survival, ki-67, RNA,